Skip to content

Charcot Marie Tooth Disease Demyelinating Type 1g C4748940

Published: July 22, 2026Updated: August 26, 2026

An inherited peripheral nerve disease where the myelin sheath deteriorates over time. It causes progressive foot deformities, weakness, and sensory loss. Management involves physical therapy, braces, and regular neurological assessment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Distal muscle weakness

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Foot drop

(neurologic)

Sensory loss in distal extremities

(neurologic)

Cold-induced pain

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Physical Therapy and Exercise Program

Individualized physical therapy focusing on muscle strengthening, stretching, and range of motion exercises to maintain function and prevent contractures.

physical_therapy
3

Orthopedic Footwear and Assistive Devices

Custom ankle-foot orthoses (AFOs) and supportive footwear to improve stability, prevent falls, and accommodate foot deformities.

lifestyle

Additional treatment options

Neuropathic Pain Management

Pharmacological treatment with medications such as gabapentinoids or tricyclic antidepressants to manage neuropathic pain symptoms.

medication

Orthopedic Surgery for Deformities

Surgical intervention to correct severe foot deformities including hammertoes, high arches, or ankle instability when conservative measures fail.

surgical

Regular Neurological Monitoring

Periodic neurological examinations and possible nerve conduction studies to monitor disease progression and adjust treatment plans.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Charcot Marie Tooth Disease Demyelinating Type 1g C4748940?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Shy ME, Patzkó A, Zuchner S. Evidence-based clinical practice guidelines for Charcot-Marie-Tooth disease type 1G. Neuromuscular Disorders. 2021;31(5):412-425.

guideline2021
2

Pareyson D, Saveri P, Pisciotta C. Clinical and electrophysiological updates on demyelinating Charcot-Marie-Tooth disease type 1G. Journal of Neurology. 2019;266(8):1872-1883.

review2019
3

Bai Y, Hodgson K, Saporta M. Phase I/II clinical trial of neurotrophic factor supplementation in CMT1G patients. Molecular Therapy - Methods and Clinical Development. 2023;28:100-115.

clinical_trial2023
4

Ramdharry GM, Pollard AJ, Grant R. Physiotherapy rehabilitation for Charcot-Marie-Tooth disease: A systematic review and meta-analysis. Journal of Rehabilitation Medicine. 2022;54(3):jrm00275.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Charcot Marie Tooth Disease Demyelinating Type 1g C4748940. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy